Latest "Cobra Biomanufacturing Plc" News Stories

10:45 EDT 26th September 2018 | BioPortfolio

Here are the most relevant search results for "Cobra Biomanufacturing Plc" found in our extensive news archives from over 250 global news sources.

More Information about Cobra Biomanufacturing Plc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cobra Biomanufacturing Plc for you to read. Along with our medical data and news we also list Cobra Biomanufacturing Plc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cobra Biomanufacturing Plc Companies for you to search.

Showing "Cobra Biomanufacturing" News Articles 1–25 of 149

Wednesday 26th September 2018

Spotlight Innovation Inc STLT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummarySpotlight Innovation Inc Spotlight Innovation, formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company's product pipeline includes drug candidates for the treatment of cancer derived from specialized receptor binding proteins found in snake venom. It also develops therapeutics for the treatment of pai...

Accruent Launches First CMMS Integration with GE Healthcare’s Service Shop Portal

Accruent, the world’s leading provider of physical resource management solutions, continues its innovation with the healthcare industry’s first Computerized Maintenance Management System (CMMS) to offer

Tuesday 25th September 2018

DirectPath and Flores & Associates Merge

Offering Concierge-Quality Health Care Transparency with Tax-Advantaged CDHPs DirectPath, the industry leader in personalized benefits education, health care transparency and compliance, today announced that it has merged with

Partnership to develop cost effective regenerative medicine

Cobra Biologics, GE Healthcare and Centre for Process Innovation will collaborate to help advance gene therapy

Cobra Biologics, GE, & CPI Enter Partnership

Three-way partnership funded by a £570K Innovate UK grant, to increase robustness & reduce costs for the mfg. of AAV vectors

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines Keele, Darlington and London, 25 September 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, today announced a collaboration with the Centre for Process Innovation (CPI), a UK-based techno...

WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board

SHANGHAI, Sept. 25, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced the appointment of David R. Liu, Professor of Chemistry and Chemical Biology at Harvard University, Richard Merkin Professor and Vice-Chair of the Faculty at the Br...

Monday 24th September 2018

Lonza adds two new Ibex solutions offerings to Swiss biopark

In July 2017 Ibex Dedicate, a modular, technology-agnostic biomanufacturing concept, was launched as the first Ibex Solutions offering. Ibex Dedicate offers an innovative facility concept with reduced CAPEX The post Lonza adds two new Ibex solutions offerings to Swiss biopark appeared first on Pharma Business review.

Friday 21st September 2018

Lonza invests $418m in two biomanufacturing solutions

Lonza announced it would invest in two new âIbex Solutionsâ, which offer manufacturing capabilities to biotechs developing antibody therapies.

Thursday 20th September 2018

BeiGene selects GE’s KUBio facility to boost cancer drugs manufacturing capacity

The KUBio biomanufacturing facility for BeiGene will be located in Guangzhou in the Chinese province Guangdong, where other biotech firms are setting up operations, said GE. It will The post BeiGene selects GE’s KUBio facility to boost cancer drugs manufacturing capacity appeared first on Pharma Business review.

Wednesday 19th September 2018

BeiGene grabs GE facility, continuing manufacturing buildout

Part of GE Healthcare's KUBio business, the facility includes FlexFactory biomanufacturing and is set to be operational — at least in part — by 2019.

Wednesday 12th September 2018

GE Healthcare to Expand OHSU Mission Control Capabilities to Support Sepsis Patient Care

OHSU is first to leverage GE Healthcare command center to support better management of sepsis care OHSU’s AI-powered Mission Control delivers proven results and continues to make an operational, clinical and financial impact GE Healthcare today announced plans to increase the capabilities of OHSU’s Mission Control...

Friday 7th September 2018

Thermo Fisher Acquiring BD's Advanced Bioprocessing Business

Thermo Fisher Scientific said it has agreed to acquire the Advanced Bioprocessing business of BD (Becton, Dickinson and Company) for an undisclosed price. BD Advanced Bioprocessing includes cell culture media, supplements, and feeds designed to work in a variety of biopharmaceutical applications—including the production of vaccines, monoclonal antibodies, and biosimilars—with the goals of ...

Thursday 6th September 2018

Forward Bio Initiative Launches with $750K Grant from WI Jobs Agency

The Wisconsin Economic Development Corp. (WEDC) said Thursday that it has awarded $750,000 in grant funding to help launch a new biomanufacturing collaboration that aims to promote technological innovation and job creation in the Badger State. As Xconomy reported in August, the groups behind the collaboration—which they’re calling the Forward Bio Initiative—are seeking to assist [...

Wednesday 5th September 2018

Alcami advancing university program backed by $1.12m workforce development grant

Alcami is working with a local university on a program designed to enhance biomanufacturing workforce education and prepare students for careers in the field.

Sunday 2nd September 2018

LakePharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17042018] Prices from USD $250

SummaryLakePharma Inc LakePharma is a biologics contract research organization that povides antibody and protein engineering, cell line development, and protein production services. The organization's services include antibody generation, antibody engineering and production, protein engineering and production, protein chemistry, protein conjugation, bioassays, DNA studio, stable cell lines, servic...

Thursday 30th August 2018

Lantheus Holdings Appoints Etienne Montagut as Senior Vice President of Corporate Development

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced that it has appointed Etienne Montagut as Senior Vice President of Corporate Development, a ...

Wednesday 29th August 2018

Cesca Therapeutics Inc KOOL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryCesca Therapeutics Inc Cesca researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cellbased therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The compan...

Monday 27th August 2018

Acura cobra protagonismo en la Semana del Automóvil de Monterey con el estreno mundial del NSX 2019

TORRANCE, California, 27 de agosto de 2018 /PRNewswire-HISPANIC PR WIRE/ -- Acura estrenó el superauto NSX 2019 y continuó su convincente presencia en Monterey al Read more...

Tuesday 21st August 2018

ATUM Receives Patent to Expand and Integrate Transposon Based Technologies for Protein Pharmaceutical Development

ATUM (formerly DNA2.0 Inc.), a pioneer in bioengineering solutions, announce the issuance of patent No. 10,041,077 by the U.S. Patent and Trademark Office (USPTO) for expanding the scope of Leap-In, the company's innovative transposon-based tool. The patent entitled "DNA vectors, transposons and transposases for eukaryotic genome modification," covers conf...

GE Healthcare, Swedish Government Open an Innovation Center in Uppsala

GE Healthcare has partnered with the government of Sweden to open a SEK 145 million (approximately $15.9 million) center in Uppsala that focuses on advancing manufacturing capabilities and the commercialization of new technologies in life sciences. Testa Center is a 2,500 square-meter (27,000-square-foot) facility that houses four bioprocessing laboratories with GE Healthcare technologies for ...

Sunday 19th August 2018

Cobra Biologics Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13042018] Prices from USD $250

SummaryCobra Biologics Ltd Cobra Biologics, formerly RecipharmCobra Biologics Ltd, a subsidiary of Cobra Biologics Holding AB, is a contract development and manufacturing organisation that offers biologics and pharmaceuticals services for preclinical, clinical and commercial supply. The organization develops and manufactures monoclonal antibodies mAb, recombinant proteins, DNA, viral vectors, micr...

Saturday 18th August 2018

Bioprocess Containers Market by Type 2D Bags, 3D Bags, Tank Liners, Application Process Development, Upstream, and Downstream, End Users Biopharmaceutical, and Life Science Companies, and Region Global Forecast to 2023 [Report Updated: 12042018] Prices f

Global bioprocess containers market projected to grow at a CAGR of 13.2% during the forecast periodThe global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 1,030.0 million in 2018, at a CAGR of 13.2%. Growth in this market can be attributed to the increasing demand for biologics, affordability and sustainability of singleuse bioprocess technologies, vaccine...

Friday 17th August 2018

Samsung looks to expand CDMO biz with $22bn investment

Samsung plans to invest KRW 180 trillion into its various businesses over the next three years, including in biomanufacturing-focused Samsung BioLogics.

Wednesday 15th August 2018

Certara’s D360 Version 10.5 Extends Platform’s Ability to Optimize Discovery Research Across Therapeutic Modalities

Certara has increased D360’s oligonucleotide research capabilities, while continuing to enhance its visualization features, workflows, and usability Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of D360 v10.5, the first in a series of ...

Quick Search


News Quicklinks